Profiel
Thomas Fuchs is currently an Independent Director at GeneDx Holdings Corp.
since 2025.
Dr. Fuchs is also the Chief Artificial Intelligence Officer & Senior VP at Eli Lilly & Co. since 2024.
Dr. Fuchs holds a doctorate from the Swiss Federal Institute of Technology and a graduate degree from Graz University of Technology.
Actieve functies van Thomas Fuchs
| Bedrijven | Functie | Begin |
|---|---|---|
| ELI LILLY AND COMPANY | Hoofd Techniek/Wetenschap/O&O | 21-10-2024 |
| GENEDX HOLDINGS CORP. | Directeur/Bestuurslid | 17-09-2025 |
Opleiding van Thomas Fuchs
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graz University of Technology
Graz University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneDx Holdings Corp.
GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
















